| __timestamp | Regeneron Pharmaceuticals, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 504755000 | 612613000000 |
| Thursday, January 1, 2015 | 838526000 | 650773000000 |
| Friday, January 1, 2016 | 1177697000 | 619061000000 |
| Sunday, January 1, 2017 | 1320433000 | 628106000000 |
| Monday, January 1, 2018 | 1556200000 | 717599000000 |
| Tuesday, January 1, 2019 | 1834800000 | 964737000000 |
| Wednesday, January 1, 2020 | 1346000000 | 875663000000 |
| Friday, January 1, 2021 | 1824900000 | 886361000000 |
| Saturday, January 1, 2022 | 2115900000 | 997309000000 |
| Sunday, January 1, 2023 | 2631300000 | 1053819000000 |
| Monday, January 1, 2024 | 2954400000 | 1053819000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of major players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Regeneron Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited from 2014 to 2023. Over this period, Takeda's SG&A expenses have consistently dwarfed those of Regeneron, with Takeda's 2023 expenses reaching over 400 times that of Regeneron's. Notably, Regeneron has shown a steady increase in SG&A expenses, peaking in 2023 with a 74% rise from 2014. Meanwhile, Takeda's expenses have surged by approximately 72% over the same period. This disparity highlights the contrasting scales and operational strategies of these pharmaceutical giants. The data for 2024 is incomplete, indicating a need for further updates to maintain accurate insights.
Cost Management Insights: SG&A Expenses for Gilead Sciences, Inc. and Takeda Pharmaceutical Company Limited
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Biogen Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Dr. Reddy's Laboratories Limited
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc. Trends and Insights
Regeneron Pharmaceuticals, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Evotec SE
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Sarepta Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Corcept Therapeutics Incorporated
Selling, General, and Administrative Costs: Takeda Pharmaceutical Company Limited vs Protagonist Therapeutics, Inc.